A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED)

NCT00701090 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1035

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus, Non Insulin Dependent
Diabetes Mellitus, Non-Insulin-Dependent

Interventions

DRUG: sitagliptin
DRUG: Comparator: glimepiride
DRUG: open-label metformin

Sponsor

Merck Sharp & Dohme LLC